JP2013520412A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013520412A5 JP2013520412A5 JP2012553848A JP2012553848A JP2013520412A5 JP 2013520412 A5 JP2013520412 A5 JP 2013520412A5 JP 2012553848 A JP2012553848 A JP 2012553848A JP 2012553848 A JP2012553848 A JP 2012553848A JP 2013520412 A5 JP2013520412 A5 JP 2013520412A5
- Authority
- JP
- Japan
- Prior art keywords
- solid form
- schizophrenia
- form according
- cognitive deficits
- xrpd pattern
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30558110P | 2010-02-18 | 2010-02-18 | |
| US61/305,581 | 2010-02-18 | ||
| PCT/SE2011/050170 WO2011102793A1 (en) | 2010-02-18 | 2011-02-17 | Solid forms comprising a cyclopropyl amide derivative |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013520412A JP2013520412A (ja) | 2013-06-06 |
| JP2013520412A5 true JP2013520412A5 (enExample) | 2014-03-20 |
| JP5746718B2 JP5746718B2 (ja) | 2015-07-08 |
Family
ID=44370079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012553848A Expired - Fee Related JP5746718B2 (ja) | 2010-02-18 | 2011-02-17 | シクロプロピルアミド誘導体からなる固体形態 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20110201622A1 (enExample) |
| EP (1) | EP2536701A4 (enExample) |
| JP (1) | JP5746718B2 (enExample) |
| KR (1) | KR20130034009A (enExample) |
| CN (1) | CN103140481A (enExample) |
| AR (1) | AR080203A1 (enExample) |
| AU (1) | AU2011218490B9 (enExample) |
| BR (1) | BR112012020780A2 (enExample) |
| CA (1) | CA2789884A1 (enExample) |
| CL (1) | CL2012002285A1 (enExample) |
| IL (1) | IL221430A0 (enExample) |
| MX (1) | MX2012009537A (enExample) |
| NZ (1) | NZ602108A (enExample) |
| RU (1) | RU2012136921A (enExample) |
| SG (1) | SG183231A1 (enExample) |
| TW (1) | TW201136898A (enExample) |
| WO (1) | WO2011102793A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0815591B8 (pt) | 2007-08-22 | 2021-05-25 | Astrazeneca Ab | composto, composição farmacêutica, e, uso de um composto. |
| TW201039825A (en) | 2009-02-20 | 2010-11-16 | Astrazeneca Ab | Cyclopropyl amide derivatives 983 |
| AU2011218492B2 (en) * | 2010-02-18 | 2014-11-13 | Astrazeneca Ab | New crystalline form of a cyclopropyl benzamide derivative |
| CN109438423A (zh) * | 2018-09-12 | 2019-03-08 | 通化师范学院 | 一种肺癌靶向化合物azd-3759的合成工艺的新方法 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE637271A (enExample) * | 1963-04-04 | 1900-01-01 | ||
| US3449427A (en) * | 1965-06-03 | 1969-06-10 | Smithkline Corp | Aminocyclopropane derivatives of 5h-dibenzo(a,d)cycloheptenes |
| US3697506A (en) * | 1970-08-07 | 1972-10-10 | Pfizer | Crystalline alkali metal salts of {60 -carboxybenzylpenicillin and process therefor |
| US3686335A (en) * | 1970-12-21 | 1972-08-22 | Smith Kline French Lab | 5-vinyl-5h-di benzo(a,d)cycloheptenes |
| US4432987A (en) * | 1982-04-23 | 1984-02-21 | Pfizer Inc. | Crystalline benzenesulfonate salts of sultamicillin |
| US4547505A (en) * | 1983-03-25 | 1985-10-15 | Degussa Aktiengesellschaft | N-Phenyl-N-'-cycloalkylalkanoylpiperazine useful as analgetics and process for its production |
| EP0435320B1 (en) * | 1989-12-29 | 1994-10-05 | Banyu Pharmaceutical Co., Ltd. | 2(2-Cyclopropylpyrrolidin-4-ylthio)-carbapenem derivatives |
| DE4131139A1 (de) * | 1991-09-19 | 1993-03-25 | Bayer Ag | Verfahren zur herstellung von 1-fluor-cyclopropan-1-carbonsaeure |
| WO1994020505A1 (en) * | 1993-03-12 | 1994-09-15 | The Upjohn Company | Crystalline ceftiofur free acid |
| WO2000000492A1 (en) * | 1998-06-26 | 2000-01-06 | Chugai Seiyaku Kabushiki Kaisha | FINE POWDER OF L-α-AMINOADIPIC ACID DERIVATIVE, ORAL SOLID PREPARATIONS CONTAINING THE SAME, AND METHOD FOR TREATMENT OF BULK POWDERS |
| US6284761B1 (en) * | 1999-01-08 | 2001-09-04 | Neurogen Corporation | 1-phenyl-4-(1-[2-aryl]cyclopropyl)methylpiperazines: dopamine receptor ligands |
| MXPA02006660A (es) * | 2000-01-07 | 2002-12-13 | Transform Pharmaceuticals Inc | Formacion, identificacion y analisis de diversas formas solidas de alto rendimiento. |
| US6521619B2 (en) * | 2000-06-29 | 2003-02-18 | Icos Corporation | Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents |
| UA75392C2 (en) * | 2001-02-23 | 2006-04-17 | Merck & Co Inc | N-substituted non-aryl heterocyclic antagonists nmda/nr2b |
| JP2005508321A (ja) * | 2001-09-26 | 2005-03-31 | メルク エンド カムパニー インコーポレーテッド | 結晶形態のエルタペネムナトリウム |
| US6861432B2 (en) * | 2001-11-23 | 2005-03-01 | Schering Aktiengesellschaft | Piperazine derivatives that destabilize androgen receptors |
| CN1642947A (zh) * | 2002-03-22 | 2005-07-20 | 株式会社Lg生命科学 | ( 2 S )－N－5－[氨基(亚氨基)甲基]－2－噻吩基甲基－1－( 2 R ) －2－[(羧甲基) 氨基]－3 ,3－二苯基丙酰－2－吡咯烷甲酰胺·nH2O的新晶形 |
| US20040209858A1 (en) * | 2002-10-22 | 2004-10-21 | Bennani Youssef L. | Cycloalkylamides and their therapeutic applications |
| US20040077618A1 (en) * | 2002-10-22 | 2004-04-22 | Bennani Youssef L. | Cycloalkylamides and their therapeutic applications |
| AU2004238447C1 (en) * | 2003-04-23 | 2009-06-11 | Glaxo Group Limited | Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases |
| AR045595A1 (es) * | 2003-09-04 | 2005-11-02 | Vertex Pharma | Composiciones utiles como inhibidores de proteinas quinasas |
| SI1948607T1 (sl) * | 2005-09-16 | 2010-07-30 | Janssen Pharmaceutica Nv | Ciklopropil amini kot modulatorji histaminskega H3 receptorja |
| KR20080085031A (ko) * | 2006-01-13 | 2008-09-22 | 에프. 호프만-라 로슈 아게 | 사이클로헥실 피페라지닐 메탄온 유도체 및 히스타민 ｈ3수용체 조절제로서의 이의 용도 |
| CN101472887A (zh) * | 2006-06-23 | 2009-07-01 | 艾博特公司 | 作为组胺h3受体调节物的环丙胺衍生物 |
| US9108948B2 (en) * | 2006-06-23 | 2015-08-18 | Abbvie Inc. | Cyclopropyl amine derivatives |
| TW200828371A (en) * | 2006-09-21 | 2008-07-01 | Matsushita Electric Industrial Co Ltd | Chip-type filter |
| BRPI0815591B8 (pt) * | 2007-08-22 | 2021-05-25 | Astrazeneca Ab | composto, composição farmacêutica, e, uso de um composto. |
| WO2009043784A1 (en) * | 2007-10-04 | 2009-04-09 | F. Hoffmann-La Roche Ag | Cyclopropyl aryl amide derivatives and uses thereof |
| AR070107A1 (es) * | 2008-01-15 | 2010-03-17 | Lilly Co Eli | R-2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran-4-il)-propionamida en forma cristalina, composicion farmaceutica que la comprende y su uso para la manufactura de un medicamento util para la prevencion o tratamiento de hiperglicemia |
| TW201039825A (en) * | 2009-02-20 | 2010-11-16 | Astrazeneca Ab | Cyclopropyl amide derivatives 983 |
| AU2011218492B2 (en) * | 2010-02-18 | 2014-11-13 | Astrazeneca Ab | New crystalline form of a cyclopropyl benzamide derivative |
-
2011
- 2011-02-17 WO PCT/SE2011/050170 patent/WO2011102793A1/en not_active Ceased
- 2011-02-17 RU RU2012136921/04A patent/RU2012136921A/ru not_active Application Discontinuation
- 2011-02-17 JP JP2012553848A patent/JP5746718B2/ja not_active Expired - Fee Related
- 2011-02-17 KR KR1020127024173A patent/KR20130034009A/ko not_active Withdrawn
- 2011-02-17 MX MX2012009537A patent/MX2012009537A/es not_active Application Discontinuation
- 2011-02-17 CN CN201180019676XA patent/CN103140481A/zh active Pending
- 2011-02-17 AR ARP110100484A patent/AR080203A1/es unknown
- 2011-02-17 EP EP20110744973 patent/EP2536701A4/en not_active Withdrawn
- 2011-02-17 CA CA2789884A patent/CA2789884A1/en not_active Abandoned
- 2011-02-17 US US13/029,351 patent/US20110201622A1/en not_active Abandoned
- 2011-02-17 AU AU2011218490A patent/AU2011218490B9/en not_active Ceased
- 2011-02-17 SG SG2012058848A patent/SG183231A1/en unknown
- 2011-02-17 NZ NZ602108A patent/NZ602108A/en not_active IP Right Cessation
- 2011-02-17 BR BR112012020780A patent/BR112012020780A2/pt not_active IP Right Cessation
- 2011-02-17 TW TW100105298A patent/TW201136898A/zh unknown
-
2012
- 2012-08-13 IL IL221430A patent/IL221430A0/en unknown
- 2012-08-17 CL CL2012002285A patent/CL2012002285A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI2534153T4 (fi) | 8-fluori-2-{4-[(metyyliamino}metyyli]fenyyli}-1,3,4,5-tetrahydro-6h-atsepino[5,4,3-cd]indol-6-onin suoloja ja polymorfeja | |
| JP2010501519A5 (enExample) | ||
| JP2021530565A5 (enExample) | ||
| JP2015501783A5 (enExample) | ||
| FI3699181T3 (fi) | Kiteinen muoto (s)-n-(5-((r)-2-(2,5-diluorifenyyli)-pyrrolidin-1-yyli)-pyratsolo[1,5-a]pyrimidin-3-yyli)-3-hydroksipyrrolidiini-1-karboksamidivetyysulfaatista | |
| JP2018531280A5 (enExample) | ||
| JP2013237682A5 (enExample) | ||
| RU2014110399A (ru) | Кристаллические формы вгс протеазного ингибитора | |
| JP2009537498A5 (enExample) | ||
| JP2014524442A5 (enExample) | ||
| JP2020519654A5 (enExample) | ||
| BRPI0811280B8 (pt) | compostos amino-heterocíclicos, composição farmacêutica que os compreende e usos dos referidos compostos | |
| JP2015512942A5 (enExample) | ||
| JP2013516473A5 (enExample) | ||
| WO2012018534A3 (en) | Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases | |
| RU2012144614A (ru) | Кристаллические формы макролида и их применение | |
| CA2727378A1 (en) | New co-crystal compound of rivaroxaban and malonic acid | |
| JP2013522367A5 (enExample) | ||
| JP2011522827A5 (enExample) | ||
| JP2016510768A5 (enExample) | ||
| JP2013520412A5 (enExample) | ||
| JP2015522589A5 (enExample) | ||
| RU2012136148A (ru) | Новая кристаллическая форма производного циклопропилбензамида | |
| JP2016513704A5 (enExample) | ||
| JP2021506898A5 (enExample) |